Trial begins for Endologix's aortic aneurysm device

03/5/2013 | American City Business Journals

Endologix is sponsoring a clinical study of its Ventana Fenestrated System, which features two branched stent grafts for maintaining blood flow in the kidneys and a main column to shield the aorta and prevent blood flow in the aneurysm. The FDA-approved trial will test whether the device is safe and effective in patients with pararenal and juxtarenal aortic aneurysms.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX